The metabolic syndrome-cancer axis: global research trends and clinical landscapes - Report - MDSpire

The metabolic syndrome-cancer axis: global research trends and clinical landscapes

  • By

  • Dianzhe Tian

  • Xinshi Li

  • Jiajie Lin

  • Zuyi Yang

  • Xinyu Zhao

  • Zixuan Hu

  • Haitao Zhao

  • Shunda Du

  • Shengzhi Liu

  • Lei Zhang

  • Yiyao Xu

  • Xin Lu

  • June 22, 2026

  • 0 min

Share

Clinical Report: Exploring the Relationship Between Metabolic Syndrome and Cancer

Background

Metabolic syndrome (MetS) is a cluster of risk factors that increases the likelihood of cardiovascular disease and diabetes. The global prevalence of MetS is rising, influenced by obesity and lifestyle changes. Research indicates that MetS contributes to a pro-tumorigenic environment, affecting cancer incidence and patient survival.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

  • Research output on MetS and cancer has increased, particularly from China and the US.
  • Thematic focus has shifted from isolated metabolic issues to integrated MetS phenotypes and cancer prognosis.
  • Bioinformatics analyses identified hub genes and pathways linking metabolic dysregulation to tumor development.
  • MetS is associated with poorer oncologic outcomes, including higher recurrence rates and reduced survival.
  • Targeted interventions for MetS components may enhance treatment efficacy in cancer patients.

Clinical Implications

Understanding the relationship between MetS and cancer can inform clinical strategies. Addressing metabolic dysfunction may enhance cancer treatment responses.

Conclusion

The analysis highlights the interplay between metabolic syndrome and cancer.

Related Resources & Content

  1. The ASCO Post, 2025 -- Metabolic Syndrome May Increase Risk of Cancer Recurrence, Subsequent Mortality Among Breast Cancer Survivors
  2. Frontiers in Oncology, 2026 -- Diabetes and cancer: clinical implications for integrated metabolic–oncologic care
  3. Frontiers in Endocrinology, 2026 -- Editorial: Changes in Metabolic Characteristics Associated with Gastrointestinal Tract Cancers, Volume II
  4. The Journal of Clinical Endocrinology & Metabolism -- Causal Effects of Metabolic Syndrome on Gastric Disorders: Univariable and Multivariable Mendelian Randomization
  5. American Cancer Society -- Guideline for Diet and Physical Activity for Cancer Survivors
  6. Metabolic Syndrome Components and Cancer Risk in Normal-Weight Subjects: Systematic Review and Meta-Analysis in over 18 Million Individuals - PMC
  7. GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
  8. American Cancer Society Guideline for Diet and Physical Activity for Cancer Survivors | American Cancer Society
  9. Metabolic Syndrome Components and Cancer Risk in Normal-Weight Subjects: Systematic Review and Meta-Analysis in over 18 Million Individuals - PMC
  10. GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

Original Source(s)

The metabolic syndrome-cancer axis: global research trends and clinical landscapes

  • by Dianzhe Tian, Xinshi Li, Jiajie Lin, Zuyi Yang, Xinyu Zhao, Zixuan Hu, Haitao Zhao, Shunda Du, Shengzhi Liu, Lei Zhang, Yiyao Xu, Xin Lu

  • June 22, 2026

Related Content

Association between radiotherapy timing and intracranial outcomes in EGFR-mutant NSCLC with brain metastases treated with EGFR-TKIs

A sequential strategy of upfront radiofrequency ablation followed by endoscopic papillectomy for complex ampullary tumors

Multiparametric MRI-based nomogram integrating clinicopathological factors for predicting HER2 expression status in breast cancer